Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has John M. Lachin's publication output changed over time?
ScholarIQpublication output · 1981–2017
Output grew100% over the shown period — from 1 works in 1981 to 2 in 2017.
1
1
1
2
1
2
2
2
19812000200420062009201520162017
What are the most-cited papers on John M. Lachin?
ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Bernard Zinman
New England Journal of Medicine. 20163,655 CitationsOPEN ACCESS
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Steven E. Kahn, Steven M. Haffner, Mark Heise, William H. Herman, Rury R. Holman, Nigel C. Jones, Barbara G. Kravitz, John M. Lachin, Mark O’Neill, Bernard Zinman, Giancarlo Viberti
New England Journal of Medicine. 20062,958 Citations
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, Keith D. Kaufman, Joerg Koglin, Scott Korn, John M. Lachin, Darren K. McGuire, Michael Pencina, Eberhard Standl, Peter P. Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D. Peterson, Rury R. Holman
New England Journal of Medicine. 20152,600 CitationsOPEN ACCESS
Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes
Richard F. Hamman, Rena R. Wing, Sharon L. Edelstein, John M. Lachin, George A. Bray, Linda M. Delahanty, Mary A. Hoskin, Andrea M. Kriska, Elizabeth J. Mayer‐Davis, Xavier Pi‐Sunyer, Judith G. Regensteiner, Beth Venditti, Judith Wylie‐Rosett
Diabetes Care. 20061,358 CitationsOPEN ACCESS
Related on ScholarIQ
Christian Doppler Laboratory for Thermoelectricity
Institution
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Paper
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Paper
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Paper
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Paper
Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes
Paper